A to Z

medicine

Featured Psychology

·January 8, 2014·3 min read

Scientists Find a New Mechanism Underlying Depression

Changes in microglia underlie depressive symptoms brought on by exposure to chronic stress, a new study reports.

This shows two heads with a psychedelic background

Featured Neuroscience Open Neuroscience Articles Psychology

·May 30, 2019·4 min read

‘Ecstasy’ shows promise for post-traumatic stress treatment

MDMA shows promise for the treatment of post-traumatic stress disorder. Combining the use of Ecstasy with psychotherapy treatments resulted in a reduction of PTSD symptoms after just one session. 54% of the study participants no longer met the PTSD criteria after two sessions. Patients also reported improvements in depression symptoms.

Brain Cancer Featured

·September 21, 2012·2 min read

‘Fingerprinting’ Breakthrough Offers Improved Brain Tumor Diagnosis

Researchers have shown that infrared and Raman spectroscopy – coupled with statistical analysis – can be used to tell the difference between normal brain tissue and the different tumor types that may arise in this tissue, based on its individual biochemical-cell ‘fingerprint’.

This shows baby Arabella Smygov following gene therapy treatment for SMA

Featured Genetics Neurology Neuroscience

·June 10, 2019·7 min read

‘Like Looking at a Miracle’: Baby Blossoms Thanks to Gene Therapy For Spinal Muscular Atrophy

Zolgensma, an FDA approved gene therapy, supplements the production of the SMN protein to improve motor neuron function in children with spinal muscular atrophy after just one dose.

This shows brain slices from the research paper

Featured Genetics Neurology Neuroscience

·February 24, 2020·4 min read

‘Resetting’ immune cells improves traumatic brain injury recovery

By inhibiting a particular receptor microglia use to survive, researchers reduced neuroinflammation and prompted recovery following traumatic brain injury in mouse models.

Featured Neuroscience Open Neuroscience Articles

·March 17, 2020·3 min read

‘Stealth Transmission’ Fuels Fast Spread of COVID-19 Outbreak

Undetected and undocumented cases of COVID-19 were largely responsible for the rapid spread of the virus in China. 86% of all infections were undocumented before the January 23 Wuhan travel shutdown. Per person, the undocumented infections were half as contagious as documented infections but were the source of two-thirds of documented infections.

This shows a cell phone, neurons and a sensor.

Featured Genetics Neuroscience Psychology

·October 29, 2025·8 min read

$2 Saliva Test Could Help Detect Depression and Schizophrenia

Scientists have developed a portable biosensor that can detect levels of BDNF, a protein linked to mental health conditions such as depression, schizophrenia, and bipolar disorder. The flexible, low-cost device analyzes a drop of saliva in under three minutes, offering a fast, affordable, and noninvasive diagnostic tool.

Featured Open Neuroscience Articles Psychology

·June 20, 2012·3 min read

1 in 8 Heart Patients Suffer PTSD

Post-traumatic stress disorder (PTSD) doubles risk of future cardiac event and death. One in eight people who suffer a heart...

Featured Genetics Neurology Neuroscience

·November 5, 2025·6 min read

3D Brain Map Reveals How Inflammation Reawakens Developmental Genes

Researchers have developed the most detailed molecular map yet of how the brain develops and reacts to inflammation, revealing that disease processes can “reawaken” genes from early life. Using a new spatial tri-omics technique, the team tracked how gene activity, epigenetic changes, and protein production interact in specific brain regions.

Featured Neuroscience Open Neuroscience Articles

·March 9, 2020·5 min read

5.1 days incubation period for COVID-19

Researchers report the median time from exposure to symptoms for the COVID-19 virus is 5.1 days. 97.5% of people who develop symptoms of coronavirus will do so within 11.5 days of exposure. For every 10,000 people quarantined for 14 days, an estimated 101 would develop symptoms after release.

This shows pills and a pestle and mortar

Featured Neurology

·April 2, 2019·2 min read

A “Low Dose Aspirin” for Dementia? Drug Ready for First in-Human Testing

MW-151, a new drug that blocks 'bad' inflammation in the brain is about to be tested in a new human trial. Researchers believe the new drug could help stave off dementia.

Featured Neuroscience

·February 29, 2020·9 min read

A big coronavirus mystery: What about the children?

Infectious disease experts report between 40% and 70% of adults could become infected with coronavirus during the outbreak. In a new interview, Dr. Lipsitch, head of Harvard's T.H. Chan School of Public Health's Center for Communicable Disease Dynamics, discusses the risks and spread potential of COVID-19, and addresses how the infection could impact children's' health.

1 2 3 … 69

medicine

Scientists Find a New Mechanism Underlying Depression

‘Ecstasy’ shows promise for post-traumatic stress treatment

‘Fingerprinting’ Breakthrough Offers Improved Brain Tumor Diagnosis

‘Like Looking at a Miracle’: Baby Blossoms Thanks to Gene Therapy For Spinal Muscular Atrophy

‘Resetting’ immune cells improves traumatic brain injury recovery

‘Stealth Transmission’ Fuels Fast Spread of COVID-19 Outbreak

$2 Saliva Test Could Help Detect Depression and Schizophrenia

1 in 8 Heart Patients Suffer PTSD

3D Brain Map Reveals How Inflammation Reawakens Developmental Genes

5.1 days incubation period for COVID-19

A “Low Dose Aspirin” for Dementia? Drug Ready for First in-Human Testing

A big coronavirus mystery: What about the children?

How Severe Illness During Pregnancy Alters Fetal Brain Development

Aging Brains Maintain Robust Language Networks Despite Cognitive Decline

Youth Protein TIMP2 Restores Immune Function in the Aging Brain

Shame, Stigma, and Culture Prevent Male Domestic Violence Survivors From Seeking Help

Subscribe